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Transcriptomics has developed into an in-
valuable tool in chemical hazard identifica-
tion (Godoy et al., 2013, 2015, 2018; Lohr et 
al., 2015; Ellinger-Ziegelbauer et al., 2011; 
Waldmann et al., 2014; Balmer et al., 2014). 
The pattern of deregulated genes in exposed 
cells gives first evidence of the involved 
mechanisms of toxicity (Rempel et al., 2015; 
Stemmer et al., 2007; Leist et al., 2017; Ro-
drigues et al., 2018). A milestone in this field 
of research was the establishment of the toxi-
cogenomics directory of chemically exposed 
human hepatocytes (Grinberg et al., 2014). A 
key message of this study was that stereotyp-
ical expression responses exist, whereby a 
similar set of genes is deregulated after expo-
sure of human hepatocytes to different com-
pounds. A relatively large fraction of these 
stereotypical stress response genes are also 
up- or downregulated in human liver disease, 
such as non-alcoholic steatohepatitis, cirrho-
sis or hepatocellular cancer (Grinberg et al., 
2014). While the human toxicogenomics di-
rectory has been widely used for follow-up 
studies, a similar database for rat hepatocytes 
has not yet been established.  
To bridge this gap, Marianna Grinberg 
and colleagues from Dortmund University re-
cently published the corresponding directory 
of rat hepatotoxicants (Grinberg et al., 2018). 
Laboratory animals offer the advantage that 
liver tissue after exposure to test compounds 
can be compared to cultivated hepatocytes ex-
posed to the same compounds. For this pur-
pose, the authors analyzed microarray expres-
sion data from 162 test substances that were 
tested in a concentration-dependent manner in 
rat livers in vivo and in cultivated hepatocytes. 
Based on this comprehensive data set genes 
were analyzed that showed a similar response 
in vitro and in vivo. Next, genes were identi-
fied that were most frequently deregulated by 
the test compounds. This resulted in seven 
genes with the highest coverage of com-
pounds (Cyp1a1, Vgt2b1, Cdkn1a, Mdm2, 
Aldh1a1, Cyp4a3 and Ehhadh). Analysis of 
these genes in hepatocytes incubated with 
compounds not present in the above men-
tioned set of 162 test substances showed that 
at least one of these seven genes was also de-
regulated in the set of independent com-
pounds. 
Currently, hepatotoxicity represents a ma-
jor research field in toxicology (Vartak et al., 
2016; Godoy et al., 2016; Bolt, 2017; Hassan, 
2016). Techniques for the reliable identifica-
tion of compounds that will induce liver in-
jury of humans are urgently needed (Stöber, 
2016; Ghallab, 2017; Paech et al., 2017). In 
this field of research the recently established 
human and rat toxicogenomics directories 
represent invaluable resources.  
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